U.S. Solicitor General Advises Supreme Court Not to Review Oklahoma PBM Regulation Law

The U.S. solicitor general has advised the Supreme Court against reviewing an Oklahoma law that regulates pharmacy benefit managers (PBMs). The recommendation aligns with a previous decision by an appeals court, which upheld three provisions of the state law challenged by a PBM trade group.

The case centers on whether certain aspects of Oklahoma’s legislation conflict with federal laws governing employee benefits and Medicare. Specifically, the PBM trade group argued that the provisions are preempted by the Employee Retirement Income Security Act (ERISA), which sets national standards for employer-sponsored health plans. The solicitor general concluded that these provisions do not interfere with ERISA or Medicare regulations and supported the appeals court’s interpretation. This development marks another step in ongoing debates over state-level efforts to regulate PBMs, entities that play a significant role in managing prescription drug benefits across the country.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

Date: May 29, 2025

Related posts:

Biologic Drug Patents Set to Expire: Over 60% Face Expiration by 2025, Driving Biosimilar Competition and New Business Models Danuglipron Development Halted After One Study Participant Shows Signs of Potential Liver Damage AI Accelerates Drug Repurposing for Neurological Disorders, Potentially Saving 90% of Development Costs Extracurricular Activities Linked to 0.5 GPA Increase, Study Finds

Author

Mark Chiang